跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Aplofe
Approved
STANDARD
Aplofe
Aristopharma Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0f336278f2d89fd2
Company
Aristopharma Ltd.
Type
Standard
Approval Details
Approval Id
0f336278f2d89fd2
Drug Approval Philippines Name
Aplofe
Product Name
Aplofe
Registration Number
DR-XY45153
Brand Name
Aplofe
Generic Name
Felodipine
Dosage Form
Extended-Release Tablet
Dosage Strength
5 mg
Manufacturer
Aristopharma Ltd.
Importer
Sahar International Trading, Inc.
Distributor
Sahar International Trading, Inc.
Issuance Date
26 April 2021
Expiry Date
18 April 2026
Pharmacologic Category
Calcium Channel Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0f336278f2d89fd2
Type
Standard
Back to Philippines FDA Approvals
Aplofe - Philippines FDA Drug Approval Details